A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- OBSERVATIONAL
- Evidence population
- Human clinical study registration
- Participants
- 300
- Population
- ALL · 65 Years
- Duration
- 2019-01-08 to 2021-03-31
- Intervention
- No intervention
- Comparator
- Not reported
- Outcomes measured
- First criteria of sarcopenia diagnostic: hand grip strength — The cohort group will be assessed in one day visit.; First criteria of sarcopenia diagnostic: knew extension strength — The cohort group will be assessed in one day visit.; First criteria of sarcopenia diagnostic: elbow flexion strength — The cohort group will be assessed in one day visit.; Second criteria of sarcopenia diagnostic: muscle mass — The cohort group will be assessed in one day visit.; Third criteria of sarcopenia diagnostic: walk speed — The cohort group will be assessed in one day visit.; Functionality: Modified Baecke Questionnaire — The cohort group will be assessed in one day visit.; Functionality: Barthel Index — The cohort group will be assessed in one day visit.; Functionality: Lawton and Brody Questionnaire — The cohort group will be assessed in one day visit.; Frailty: Fried Scale — The cohort group will be assessed in one day visit.; Frailty:Frail Scale — The cohort group will be assessed in one day visit.; Frailty: Kihon Check List (KCL) — The cohort group will be assessed in one day visit.; Comorbidity — The cohort group will be assessed in one day visit.
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: older adult. Study type is explicitly identified as OBSERVATIONAL.
Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.
